Schedule a Consult
 
 
Schedule a Consult

Infertility is a growing concern for many couples trying to conceive, and one question that frequently arises is whether stress can impact fertility.

Can Stress Cause Infertility?

Can stress cause infertility?

Infertility is a growing concern for many couples trying to conceive, and one question that frequently arises is whether stress can impact fertility. While stress alone may not be the sole cause of infertility, scientific research suggests that chronic stress can negatively affect reproductive health in both men and women.

How Stress Affects Female Fertility

1. Hormonal Imbalance

When a woman is under constant stress, her body releases high levels of cortisol and adrenaline, which can disrupt the delicate balance of reproductive hormones such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are crucial for ovulation, and any imbalance can lead to irregular cycles or anovulation (lack of ovulation).

2. Irregular Menstrual Cycles

Chronic stress can interfere with the hypothalamus-pituitary-ovarian (HPO) axis, leading to delayed or missed periods. This makes it difficult to predict ovulation, reducing the chances of conception.

3. Impact on the Uterus

High stress levels may lead to reduced blood flow to the uterus, which can affect the uterine lining’s ability to support implantation, increasing the risk of early pregnancy loss.

4. Emotional Factors

The anxiety of trying to conceive itself can create a vicious cycle, making it even harder for couples to get pregnant. Worrying about fertility can lead to increased stress, further disrupting reproductive health.

How Stress Affects Male Fertility

1. Reduced Sperm Quality

Studies show that men who experience high levels of chronic stress tend to have lower sperm count, decreased motility, and higher levels of abnormal sperm morphology. This directly impacts fertility and the ability to conceive.

2. Lower Testosterone Levels

Stress is linked to increased production of cortisol, which suppresses testosterone levels. Low testosterone can lead to reduced libido and erectile dysfunction, further complicating fertility.

3. Unhealthy Coping Mechanisms

Many men under stress resort to unhealthy habits such as smoking, excessive alcohol consumption, poor diet, and lack of exercise, all of which negatively impact sperm production and overall reproductive health.

Can Reducing Stress Improve Fertility?

Managing stress effectively can have a positive impact on fertility. Here are some proven strategies:

Stress management tips for fertility

Practice Mindfulness & Meditation

Helps lower cortisol and maintain hormonal balance.

Regular Exercise

Improves circulation, reduces stress, and supports reproductive function.

Balanced Diet

Eating nutrient-rich foods supports hormonal balance and overall reproductive health.

Quality Sleep

Ensuring 7-8 hours of restful sleep helps hormonal regulation and reduces stress-related complications.

Professional Help

Therapy or counseling can help manage emotional stress related to infertility, especially for couples undergoing IVF or ART.

Final Thoughts

While stress alone may not directly cause infertility, it can significantly influence reproductive health and make conception more difficult. By managing stress effectively, individuals and couples can create a healthier environment for fertility and increase their chances of a successful pregnancy.

Learn more about fertility and emotional wellness at the best ivf centre in west delhi.


Can Stress Cause Infertility? | Akanksha IVF Centre Janakpuri

electronic devices affect fertility in several ways both directly n indirectly

Can Electronic Devices Affect Fertility?

Electronic devices can affect fertility in several ways — both directly and indirectly. While research is still evolving, evidence suggests that smartphones, laptops, and Wi-Fi may impact reproductive health through heat, radiation, blue light, and lifestyle disruption.

1. Electromagnetic Radiation (EMR) and Exposure to Devices

Smartphones, laptops, tablets, Wi-Fi routers, and even microwaves emit electromagnetic radiation (EMR), particularly non-ionizing radiation, which is low-energy but constantly present.

Potential Effects on Male Fertility

Heat and Sperm Quality

Devices kept in pockets or on laps generate heat that may impair sperm motility and count. The scrotum is highly sensitive to temperature changes.

Studies on EMR and Sperm Health

Some studies have shown that EMR exposure might reduce sperm quality, including motility and morphology. A 2011 study linked extended mobile phone use with lower sperm count.

Potential Effects on Female Fertility

Ovarian Health

Animal studies show EMR may affect ovarian reserves or hormone levels. Human research is still limited but suggests potential risks.

Hormonal Balance Disruption

Long-term EMR exposure could influence the endocrine system, possibly affecting menstrual cycles and ovulation.

2. Blue Light and Sleep Disruption

Devices emit blue light that interferes with melatonin production, disrupting sleep and hormonal balance essential for reproductive health.

Melatonin and Hormonal Impact

Low melatonin levels can disturb estrogen, progesterone, and testosterone levels, making conception harder.

Effects on Ovulation and Testosterone

Sleep issues are linked to irregular cycles in women and reduced testosterone in men — both affecting fertility.

3. Wi-Fi and Radiation Exposure

Wi-Fi and Bluetooth constantly emit low-level radiation. Though research is limited, concerns about long-term exposure persist.

Male Sperm Count and Motility

Animal studies suggest reduced sperm quality due to prolonged exposure to Wi-Fi radiation, but human evidence is still inconclusive.

Ovarian and Hormonal Effects

Continuous exposure may affect hormone regulation in women, though more research is needed.

4. Laptop Use and Male Fertility

Heat Effects

Laptops placed on the lap can increase testicular temperature, affecting sperm production. Studies show this may lower sperm concentration and motility.

Suggestions for Prevention

  • Use laptops on desks or stands instead of laps
  • Utilize cooling pads to reduce heat exposure

5. Use of Headphones and Wireless Earbuds

Bluetooth devices emit radiation. While fertility effects are unclear, combined EMR exposure is a growing area of concern.

Proximity to the Brain

Though not directly linked to fertility, continuous exposure to Bluetooth radiation near the brain raises broader health questions.

6. Social and Lifestyle Effects of Excessive Device Use

Reduced Physical Activity

Screen-heavy habits reduce exercise and increase obesity risk — a known fertility barrier for both genders.

Mental Health and Stress

Constant online connectivity increases anxiety and stress, disrupting hormone levels and affecting ovulation and sperm quality.

7. Radiation from Medical Devices (X-rays, CT Scans)

Repeated exposure to medical radiation, especially in the pelvic area, can damage reproductive organs and reduce fertility potential.

Summary of Key Points

  • EMR and heat from mobile devices may impair sperm quality.
  • Blue light and sleep disturbances affect hormonal balance.
  • Wi-Fi and Bluetooth radiation risks remain under investigation.
  • Sedentary lifestyle and stress from device use indirectly impact fertility.

What Can Be Done

  • Limit prolonged device exposure near reproductive organs
  • Use laptops on tables with cooling pads
  • Reduce blue light exposure before bedtime
  • Exercise regularly, eat healthy, and manage stress
  • Use hands-free tools to avoid direct phone contact with body

Final Thoughts

While electronic devices are essential to modern life, mindful use can reduce risks to fertility. For couples planning to conceive, moderating screen time and protecting reproductive health can make a meaningful difference.

Concerned about fertility? Visit Akanksha IVF Centre for advanced treatment and emotional support.

al” href=”https://www.akankshaivfcentre.com/blog/electronic-devices-affect-fertility” />

Can Electronic Devices Affect Fertility? | Akanksha IVF Centre

unlocking the future with new advancements in ivf

Unlocking the Future: How Advancements in IVF Are Shaping the Next Generation

In recent years, in vitro fertilization (IVF) has undergone groundbreaking innovations that are transforming reproductive medicine. As fertility challenges become more common, modern advancements in IVF are improving outcomes and expanding access for individuals and couples worldwide.

1. Genetic Screening and CRISPR Technology

Preimplantation Genetic Testing (PGT)

PGT helps identify chromosomal abnormalities before implantation, increasing the chances of healthy pregnancies and reducing miscarriage risk.

CRISPR and Gene Editing

Though still under clinical research, CRISPR could one day correct genetic mutations in embryos, minimizing hereditary conditions.

2. Artificial Intelligence (AI) and Machine Learning

AI in Embryo Selection

AI analyzes embryo data to choose the most viable ones, enhancing IVF success rates with data-driven precision.

Personalized IVF Protocols

Machine learning helps customize hormone treatments to individual patient profiles, reducing side effects and improving efficiency.

3. Improved Egg Freezing and Ovarian Preservation

Vitrification Techniques

Ultra-rapid freezing methods protect eggs from damage and improve post-thaw viability.

Ovarian Tissue Freezing

This innovation offers fertility hope to women undergoing cancer treatment or at risk of premature ovarian failure.

4. Advances in Cryopreservation and Sperm Storage

Improved sperm and egg freezing methods are expanding fertility options for men, single parents, and LGBTQ+ couples.

5. Fertility Preservation for Transgender Individuals

Inclusive options like sperm and egg freezing before gender-affirming treatments offer family-building paths to transgender individuals.

6. Culture Media and Embryo Incubators

Time-Lapse Imaging

New incubators with time-lapse monitoring ensure embryo growth is carefully tracked without disruption.

7. Reducing Costs and Expanding Access

Subscription Models

New pricing structures allow patients to pay fixed fees for multiple cycles, easing the financial burden of IVF.

Telemedicine in IVF

Virtual consultations are helping individuals in remote areas access fertility care without travel limitations.

8. Ethical and Regulatory Developments

Emerging ethical concerns—such as gene editing, embryo banking, and reproductive rights—are shaping the legal and moral landscape of IVF globally.

Conclusion: The Future of IVF Is Inclusive, Smart, and Hopeful

As IVF technology evolves, it’s becoming more personalized, ethical, and accessible. From gene testing to AI and telemedicine, the future of fertility care promises healthier outcomes and broader access for all hopeful parents.

Unlocking the Future: How Advancements in IVF Are Shaping the Next Generation</head></p> <article> <h1>Top 10 Male Infertility Myths Debunked</h1> <p>Male infertility is often surrounded by outdated beliefs and misinformation. Understanding the facts is essential for couples on the path to parenthood. Let’s break down the most common myths and uncover the truth.</p> <h2>Myth 1: Infertility Is Solely a Female Issue</h2> <p><strong>Fact:</strong> Male infertility contributes to 40-50% of all infertility cases. Both partners should be evaluated during fertility assessments.</p> <h2>Myth 2: If a Man Fathers One Child, He Can Easily Have More</h2> <p><strong>Fact:</strong> Fertility can change due to aging, lifestyle, medical conditions, or environmental factors. Prior fatherhood doesn’t guarantee future fertility.</p> <h2>Myth 3: Tight Underwear Causes Infertility</h2> <p><strong>Fact:</strong> While excessive heat may affect sperm production, moderate use of snug underwear has minimal impact. Lifestyle and health factors are more influential.</p> <h2>Myth 4: Only Older Men Face Fertility Issues</h2> <p><strong>Fact:</strong> Young men can also experience infertility due to hormone imbalances, infections, or genetic issues. Age is just one factor.</p> <h2>Myth 5: Infertility Is Always a Medical Problem</h2> <p><strong>Fact:</strong> Lifestyle habits like smoking, poor diet, obesity, and alcohol use are major contributors to male infertility.</p> <h2>Myth 6: Infertility Comes With Obvious Symptoms</h2> <p><strong>Fact:</strong> Most men with infertility have no visible signs. A semen analysis is often the only way to detect issues.</p> <h2>Myth 7: Men Produce Sperm Forever Without Issues</h2> <p><strong>Fact:</strong> Sperm production can decline with age and may be affected by medical conditions, medications, and lifestyle factors.</p> <h2>Myth 8: Infertility Treatments for Men Are Always Invasive</h2> <p><strong>Fact:</strong> Many treatments are non-invasive and affordable. Options include dietary changes, hormone therapy, and medications.</p> <h2>Myth 9: Stress Doesn’t Affect Male Fertility</h2> <p><strong>Fact:</strong> Chronic stress can disrupt hormone levels and impair sperm production, lowering fertility rates.</p> <h2>Myth 10: Supplements Instantly Fix Fertility</h2> <p><strong>Fact:</strong> While some supplements can support reproductive health, no supplement guarantees instant results. A medical consultation is essential.</p> <h3>Understanding the Truth Behind Male Infertility</h3> <p>Educating yourself about male fertility can reduce stigma and encourage proactive care. Accurate diagnosis, lifestyle changes, and timely treatment can significantly improve fertility outcomes.</p> <h4>When to Seek Help</h4> <p>If you’ve been trying to conceive for over a year without success (or 6 months if you’re over 35), it’s time to consult a fertility specialist. Both partners should be evaluated together.</p> <h4>Final Thoughts</h4> <p>Male infertility is more common than many realize and is often treatable. Don’t let outdated myths delay your journey to parenthood. Trust science, seek support, and take action early.</p> </article> <p> <head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="description" content="Debunking common myths about male infertility. Learn the truth about causes, symptoms, and treatment options for male reproductive health."><meta name="keywords" content="male infertility, male fertility myths, sperm health, infertility treatment, causes of male infertility, sperm analysis, lifestyle and fertility, reproductive health"><meta name="author" content="Akanksha IVF Centre"><title>Top 10 Male Infertility Myths Debunked | Akanksha IVF

Stem Cell Therapy in IndiaStem Cell Therapy for Fertility in India

Stem cell therapy has emerged as one of the most promising advancements in medical science. By harnessing the body’s natural ability to heal, stem cells are now at the forefront of treatments for a variety of chronic and degenerative conditions. In this blog, we explore the science, current applications, and future of stem cell therapy in 2025 and beyond.

What Are Stem Cells?

Stem cells are unique, undifferentiated cells capable of self-renewal and specialization into various cell types.

Types of Stem Cells

  • Embryonic Stem Cells: Pluripotent and capable of becoming any type of cell.
  • Adult Stem Cells: Found in organs and tissues; limited differentiation abilities.
  • Induced Pluripotent Stem Cells (iPSCs): Adult cells genetically reprogrammed to behave like embryonic stem cells.

Applications of Stem Cell Therapy

1. Regenerative Medicine

Used to repair or replace damaged tissues in heart disease, stroke, and spinal cord injuries.

2. Hematopoietic Stem Cell Transplants

Widely used in treating blood disorders like leukemia and lymphoma.

3. Orthopedic and Joint Treatments

Effective in cartilage regeneration, treating osteoarthritis and joint degeneration.

4. Neurodegenerative Conditions

Research is ongoing for using stem cells in conditions like Alzheimer’s, Parkinson’s, and MS.

5. Diabetes and Pancreatic Repair

Potential to regenerate insulin-producing cells in diabetic patients.

How Stem Cell Therapy Works

Stem cells repair tissue by differentiating into specialized cells and releasing growth factors that promote healing.

Challenges and Considerations

1. Ethical Concerns

Embryonic stem cell research continues to raise ethical questions around consent and source.

2. Risk of Tumor Formation

Improperly managed stem cell growth can lead to tumors.

3. Immune System Rejection

Rejection risk exists when donor cells are used.

Clinical Trials and Innovations in 2025

Ongoing clinical trials in 2025 are exploring uses in heart repair, spinal cord regeneration, and gene-edited cell treatments using CRISPR technology.

Regulatory Framework

Stem cell therapy is regulated by health authorities like the FDA, ICMR, and EMA to ensure safety, ethics, and effectiveness.

Future of Stem Cell Therapy

Gene Editing & CRISPR Integration

Gene editing is enabling correction of genetic defects at the stem cell level, offering customized treatment options.

Personalized Regenerative Medicine

Patient-specific stem cells are reducing rejection risk and enabling tailored treatments.

Stem Cell Banking

Umbilical cord and tissue banking are making stem cells more readily available for future treatments.

Conclusion

Stem cell therapy represents a powerful shift in how we approach healing and chronic disease treatment. With ongoing innovations and increasing clinical applications, 2025 is set to be a transformative year in regenerative medicine. Stay informed, and consult with healthcare professionals to understand if stem cell therapy is right for your condition.

Stem Cell Therapy: Future of Regenerative Medicine in 2025

Top 10 Advanced IVF Technologies Improving Fertility Success in 2025

Updated: June 7, 2025

Advanced IVF technologies have revolutionized fertility treatment outcomes in recent years. In 2025, couples and individuals struggling with infertility have access to a wide range of innovative tools and techniques that significantly increase their chances of successful conception and healthy pregnancy. Here are the top 10 technologies making a difference:

1. ICSI (Intracytoplasmic Sperm Injection)

This technique involves injecting a single sperm directly into an egg. It’s especially effective in treating male infertility issues and ensures a higher fertilization rate.

2. PGT (Preimplantation Genetic Testing)

PGT allows for early detection of genetic abnormalities in embryos. This screening increases the likelihood of a healthy pregnancy and reduces the risk of inherited disorders.

3. Embryo Cryopreservation

Freezing embryos enables couples to delay pregnancy while retaining high-quality embryos for future use, avoiding repeated IVF cycles.

4. Time-Lapse Imaging

This technology captures embryo development in real-time, helping embryologists select the most viable embryos for transfer, improving success rates.

5. Egg and Sperm Vitrification

Vitrification is a rapid-freezing method that protects reproductive cells from damage, enhancing long-term storage success and fertility preservation options.

6. Natural Cycle IVF

This method retrieves naturally matured eggs without heavy hormone stimulation. It’s ideal for women seeking a low-intervention approach or those sensitive to medication.

7. Fertility Preservation

Egg and sperm freezing have become critical for cancer patients and those delaying parenthood, offering a reliable way to preserve fertility potential.

8. Assisted Hatching

This technique creates a tiny opening in the embryo’s shell to facilitate implantation into the uterine lining, especially helpful for older women or previous IVF failures.

9. Luteal Phase Support

Hormonal support after embryo transfer helps prepare the uterine lining for implantation, increasing the odds of successful pregnancy outcomes.

10. Personalized Medicine

Genetic and metabolic profiling allows clinics to tailor IVF protocols for each patient, making treatments more effective and reducing unnecessary interventions.

Conclusion

The future of fertility treatments is being shaped by technological innovation. With these advanced IVF tools available in 2025, patients now have better outcomes, safer procedures, and more options for starting a family. If you’re considering IVF, consult a fertility specialist to explore which technologies may benefit your unique journey.

Top 10 Advanced IVF Technologies Improving Fertility Success in 2025








How PCOS Affects Fertility and How IVF Can Help in 2025

Polycystic ovary syndrome (PCOS) is one of the most common causes of female infertility, but many women with PCOS successfully conceive with the help of in vitro fertilization (IVF). Here’s what you need to know.

How PCOS Impacts Fertility

  • Irregular Ovulation: PCOS often disrupts the regular release of eggs, making natural conception difficult.
  • Hormonal Imbalance: Elevated androgens (male hormones) can interfere with the development and release of eggs.

IVF for Women with PCOS

IVF can bypass many of the challenges posed by PCOS by managing egg development and fertilization in a controlled environment.

1. Controlled Ovarian Stimulation

Women with PCOS may require a tailored stimulation protocol to encourage egg production while minimizing the risk of ovarian hyperstimulation syndrome (OHSS).

2. Egg Retrieval

Once the ovaries are stimulated, mature eggs are retrieved under ultrasound guidance for fertilization in the lab.

3. Fertilization and Embryo Transfer

Healthy eggs are fertilized with sperm, and viable embryos are transferred to the uterus to initiate pregnancy.

Special Considerations for PCOS and IVF

  • Personalized Protocols: IVF treatment for PCOS must be customized to each woman’s hormone levels, ovarian reserve, and response to stimulation drugs.
  • Medical Supervision: A fertility specialist experienced in treating PCOS is essential for success and safety.

IVF Success Rates for PCOS

Success rates for IVF in women with PCOS are generally favorable, especially when combined with lifestyle changes and early intervention. Factors like age, weight, and egg quality still play a major role.

Final Thoughts

PCOS can make natural conception challenging, but IVF offers a highly effective path to pregnancy. With expert care and the right approach, many women with PCOS become mothers. If you’re considering IVF, consult with a fertility specialist to create a treatment plan that meets your needs.


How PCOS Affects Fertility and How IVF Can Help in 2025

Risks of Multiple Births in IVF: What to Know in 2025

Multiple births are a well-recognized risk associated with in vitro fertilization (IVF) and other assisted reproductive technologies. Understanding these risks and how they can be managed is crucial for a healthy pregnancy and delivery.

Risks of Multiple Births in IVF

1. Increased Pregnancy Complications

  • Preterm Birth: Higher risk of early delivery, leading to potential respiratory and developmental issues.
  • Preeclampsia: A common complication in multiple pregnancies that increases risks for both mother and babies.
  • Gestational Diabetes: More likely in multiple pregnancies, impacting overall pregnancy health.

2. Delivery Complications

  • Cesarean Section: More common due to abnormal fetal positions or uterine overdistension.
  • Uterine Overdistension: Carrying multiple babies can strain the uterus, complicating labor and delivery.

3. Neonatal Risks

  • Low Birth Weight: More likely with multiple births, increasing risk of complications after delivery.
  • Respiratory Problems: Premature or underweight babies often experience breathing difficulties.

4. Long-Term Health Issues

  • Developmental Delays: May occur due to prematurity and low birth weight.
  • Increased Medical Needs: Multiple births can require ongoing pediatric and developmental care.

Factors Influencing the Risk of Multiple Births

  • Number of Embryos Transferred: More embryos mean higher chances of multiples, which is why many clinics now promote single embryo transfer (SET).
  • Maternal Age: Older women may receive more aggressive protocols, increasing risk of multiples.
  • Type of IVF Protocol: Some ovarian stimulation methods increase egg production.
  • PCOS: Women with PCOS often produce more eggs, raising the potential for multiple embryos.

Managing the Risks

  • Single Embryo Transfer (SET): A key method for reducing the risk of multiple pregnancies.
  • Regular Monitoring: Early detection and management of complications through routine ultrasounds and checkups.
  • Patient Education: Knowing the risks helps families make informed choices about IVF treatment options.
  • Health Management: Maintaining a healthy weight, managing conditions like PCOS, and following medical advice can improve outcomes.

Final Thoughts

While IVF increases the chance of multiple births, careful planning and individualized treatment can minimize the risks. Discuss your options thoroughly with a fertility specialist to find the safest and most effective path to pregnancy.

Risks of Multiple Births in IVF: What to Know in 2025

Impact of Diet on ART and Fertility: Optimizing Health in 2025

Diet can have a significant impact on both Antiretroviral Therapy (ART) and fertility, influencing effectiveness, side effects, and overall reproductive health. Understanding these effects is key to optimizing health outcomes.

Impact of Diet on ART

1. Medication Absorption

  • High-fat meals: Can increase the absorption of certain ART drugs like raltegravir.
  • Grapefruit juice: May interfere with metabolism of drugs like protease inhibitors, causing side effects or reduced efficacy.

2. Nutrient Interactions

  • Tenofovir: May impact calcium and vitamin D due to effects on kidney function.
  • Ritonavir: Can alter the metabolism of various vitamins and minerals.

3. Managing Side Effects

  • Gastrointestinal symptoms: Small, frequent meals can help manage nausea or upset stomach.
  • Weight fluctuations: A tailored, balanced diet helps maintain a healthy body weight.

4. Overall Health Support

Good nutrition enhances immune function and helps maintain long-term ART effectiveness and quality of life.

Impact of Diet on Fertility

1. Nutritional Status

Essential nutrients like folic acid, zinc, iron, and omega-3s are vital for reproductive health in men and women.

2. Hormonal Balance

  • Healthy fats: Support hormone production.
  • Low GI diets: May improve fertility in people with PCOS.

3. Body Weight

  • Underweight: Can cause menstrual irregularities or low sperm count.
  • Overweight: Linked to insulin resistance and hormonal imbalance.

4. Dietary Patterns

  • Antioxidant-rich foods: Improve sperm quality and ovarian function.
  • Limit alcohol & caffeine: Excessive intake can impair fertility.

Combining ART and Fertility Nutrition

  • Consult healthcare providers: Ensure diet supports both ART treatment and fertility goals.
  • Monitor food–drug interactions: Know which foods may interfere with ART medications.

Conclusion

A well-balanced diet is essential for optimizing both ART effectiveness and fertility. Personalized nutrition advice from healthcare providers ensures safe and effective support for reproductive goals while on ART.



Impact of Diet on ART and Fertility: Optimizing Health in 2025

Ectopic Pregnancy and IVF: Risks, Diagnosis & Prevention

Ectopic Pregnancy and IVF: Risks, Diagnosis & Prevention

An ectopic pregnancy occurs when a fertilized egg implants outside the uterus, often in a fallopian tube. This is a potentially life-threatening condition requiring prompt medical attention.

Why It Matters in IVF

While IVF is designed to place embryos directly into the uterus, there’s still a small chance of an ectopic pregnancy. Let’s understand how and why this can happen.

IVF Procedure

During IVF, fertilized embryos are transferred into the uterus. However, if the fallopian tubes are damaged or if embryo migration occurs, there’s a risk of ectopic implantation.

Risk Factors

  • History of tubal surgery or infections
  • Previous ectopic pregnancies
  • Endometriosis or pelvic inflammatory disease (PID)
  • Use of fertility drugs

Diagnosis

Early ultrasound and blood tests (like hCG monitoring) help confirm whether the pregnancy is correctly located inside the uterus or is ectopic.

Treatment Options

  • Medication: Methotrexate is commonly used to stop ectopic tissue growth if detected early.
  • Surgery: Laparoscopic surgery may be needed if the fallopian tube has ruptured or the pregnancy is advanced.

Preventive Measures

  • Careful embryo placement during IVF
  • Screening for tubal abnormalities before treatment
  • Close monitoring post-embryo transfer

Final Thoughts

Though the risk of ectopic pregnancy during IVF is low, being aware of the signs and working closely with your fertility specialist ensures timely intervention and safety throughout your reproductive journey.

Ectopic Pregnancy and IVF: Risks, Diagnosis & Prevention


Male Infertility: Common Types and Causes

Male infertility can result from various factors affecting sperm production, function, or delivery. Here are some common types and causes:

Azoospermia

This condition is characterized by the absence of sperm in the ejaculate. It can be caused by blockages in the reproductive tract, hormonal imbalances, or genetic factors.

Oligospermia

This refers to a low sperm count. The number of sperm in the ejaculate is lower than normal, reducing the chances of fertilizing an egg.

Asthenozoospermia

This is when sperm have reduced motility, meaning they move more slowly or less effectively.

Teratozoospermia

Sperm with abnormal morphology (shape) may have difficulties penetrating the egg, impacting fertility.

Hypospermia

A condition characterized by a lower-than-normal volume of ejaculate.

Cryptozoospermia

A rare condition where sperm are present in very low numbers and may only be detected using advanced lab techniques.

Ejaculatory Duct Obstruction

This occurs when the ducts that transport sperm from the testes to the urethra are blocked.

Hormonal Imbalances

Imbalances in testosterone, FSH, and LH can affect sperm production and quality.

Genetic Factors

Conditions like Klinefelter syndrome or Y chromosome deletions can impair sperm production.

Varicocele

Enlargement of veins within the scrotum can raise testicular temperature and reduce sperm production.

Infections

Sexually transmitted infections or mumps can damage the reproductive tract.

Lifestyle Factors

Smoking, excessive alcohol, obesity, and environmental toxins negatively affect sperm quality.

Medical Treatments

Chemotherapy, radiation, and certain medications can impair sperm production.

Diagnosis & Treatment

Diagnosis includes semen analysis, hormone testing, genetic screening, and physical exams. Treatment options vary and may involve medication, surgery, or assisted reproductive technologies like IVF.

Consult with a fertility specialist to identify the exact cause and the most effective treatment plan.

Male Infertility: Common Types and Causes | Akanksha IVF Centre






10 Important Things to Know Before Freezing Your Eggs

Updated for 2025 | Fertility Preservation Tips for Women

1. Age and Egg Quality

The younger you are, the better the quality and quantity of your eggs. For optimal results, consider freezing your eggs in your late 20s to early 30s.

2. Cost

Egg freezing can be costly. Consider expenses for medications, retrieval, freezing, and annual storage fees.

3. Procedure Timeline

The process usually takes 2 to 4 weeks and includes ovarian stimulation, monitoring, egg retrieval, and freezing.

4. Hormonal Medication

You’ll take hormones to stimulate egg production. Side effects may include bloating, mood swings, and fatigue.

5. Egg Retrieval

This minor surgical procedure is done under sedation to collect eggs from your ovaries. Mild discomfort and quick recovery are common.

6. Success Rates

Success varies by age and egg quality. Freezing younger eggs typically yields better future IVF outcomes.

7. Emotional and Physical Impact

Be prepared for both physical demands and emotional stress. Support and counseling can be helpful.

8. Fertility Specialist Consultation

Consult a fertility expert to assess your health and options. Personalized advice helps in making informed decisions.

9. Future IVF Cycles

Using frozen eggs involves thawing, fertilization, and implantation. Success depends on egg and sperm quality.

10. Legal and Ethical Considerations

Understand legal agreements, storage policies, and consent forms before proceeding. Clinic policies can vary.



10 Important Things to Know Before Freezing Your Eggs (2025 Guide)




Egg Freezing Cost in India (2025) & Birth from 30-Year-Old Frozen Embryos

Egg Freezing Cost in India – 2025 Overview

The cost of egg freezing in India can vary based on several factors, including the clinic, location, and specific services provided.
As of 2024, here’s a general breakdown of the costs you might encounter:

  • Initial Consultation and Evaluation: ₹2,000 to ₹5,000
  • Ovarian Stimulation and Monitoring: ₹40,000 to ₹60,000 (includes medications and tests)
  • Egg Retrieval Procedure: ₹30,000 to ₹50,000
  • Egg Freezing and Storage (1 year): ₹30,000 to ₹50,000
  • Annual Storage Fee (after 1st year): ₹10,000 to ₹20,000

Total estimated initial cost: ₹1,00,000 to ₹1,65,000.

Please note: Costs can fluctuate. It’s advisable to contact individual clinics for the most current pricing. Some also offer
packages or EMI options.

Twins Born from Embryos Frozen for 30 Years

In a remarkable medical event, a couple recently welcomed twins conceived from embryos that had been frozen for 30 years. This groundbreaking birth sets a new record and showcases the long-term viability of embryo preservation.

The embryos were originally frozen in 1992 and stored under cryogenic conditions until being transferred in 2022. This milestone reaffirms the success rates and durability of embryo freezing technologies in assisted reproductive treatments.

Such stories provide hope and expanded possibilities for individuals and couples considering fertility preservation.



Egg Freezing Cost in India (2025) & 30-Year-Old Embryo Birth










What Is the Best Age to Freeze Your Eggs?

Updated: June 2025

The best age to freeze your eggs generally depends on various personal and medical factors, but many experts recommend considering egg freezing in your late 20s to early 30s. Here’s why:

1. Egg Quality and Quantity

Women are born with a finite number of eggs, and both the quantity and quality of eggs decline with age. By freezing eggs at a younger age, you are more likely to have a higher number of healthy eggs, which can improve the chances of a successful pregnancy later.

2. Success Rates

Research indicates that younger eggs tend to have better success rates for IVF and future pregnancies. For example, eggs frozen in your late 20s or early 30s often have higher success rates compared to those frozen in your late 30s or 40s.

3. Future Planning and Flexibility

Egg freezing can provide a form of fertility insurance if you choose to delay having children due to personal or professional reasons. Freezing eggs earlier gives you greater flexibility and options later in life.

4. Health Considerations

The procedure for egg retrieval is generally less complex and carries fewer risks when performed on younger women. Overall health can also be better in younger years, which might affect the procedure’s success and recovery positively.

Note: Individual circumstances vary. It’s essential to consult with a fertility specialist who can offer personalized advice based on your medical history, fertility status, and long-term goals.


Best Age to Freeze Eggs – Fertility Preservation Guide (2025)






In Vitro Fertilization (IVF): Step-by-Step Process

Learn how IVF works to help with fertility issues. This guide covers ovarian stimulation, fertilization, embryo transfer, and more.

Step 1: Ovarian Stimulation

Fertility medications are used to stimulate the ovaries to produce multiple eggs. This improves the chances of retrieving healthy eggs for fertilization.

Step 2: Egg Retrieval

The mature eggs are collected via transvaginal ultrasound aspiration, a minor surgical procedure using a needle to access the ovaries through the vaginal wall.

Step 3: Sperm Collection

A sperm sample is obtained from a partner or donor, processed in a lab to isolate the healthiest sperm for use in fertilization.

Step 4: Fertilization

The eggs and sperm are combined in a lab dish. In some cases, intracytoplasmic sperm injection (ICSI) is used to inject a single sperm into an egg.

Step 5: Embryo Culture

The fertilized eggs (embryos) are monitored for several days. The best quality embryos are selected for transfer.

Step 6: Embryo Transfer

One or more embryos are transferred into the uterus using a catheter. This step is usually painless and doesn’t require anesthesia.

Step 7: Pregnancy Test

Approximately two weeks after the embryo transfer, a blood test determines whether implantation has occurred and pregnancy has begun.


IVF Process Step-by-Step | Fertility Treatment Guide 2025

Why IVF in India is More Accessible and Streamlined

Explore key factors that make India a leading destination for IVF treatment in 2025.

Key Advantages of IVF in India

  • Cost-Effectiveness:

    IVF in India is significantly more affordable than in many Western nations. Lower costs come with high standards of care, making it ideal for both domestic and international patients.

  • High-Quality Medical Infrastructure:

    Modern IVF clinics equipped with state-of-the-art technology and international accreditation ensure global standards of care.

  • Experienced Professionals:

    India’s fertility specialists and embryologists are highly trained, often with international experience, ensuring top-tier reproductive care.

  • Regulatory Environment:

    India has a supportive and evolving legal framework for assisted reproductive technologies, protecting patient rights and ensuring ethical treatment.

  • Personalized Care:

    Clinics offer tailored treatment plans, comprehensive support, and lifestyle guidance to ensure better outcomes.

  • Supportive Ecosystem:

    Many IVF clinics provide services for international patients, including visa assistance, travel support, and accommodation arrangements.

  • Availability of Donor Services:

    A wide range of donor options (egg, sperm, embryo) makes IVF accessible to those with specific fertility needs.

  • Shorter Waiting Times:

    Compared to countries with long waiting lists, India offers quicker access to IVF procedures.

These advantages make IVF in India an increasingly attractive and practical option for individuals and couples worldwide.

Why IVF in India is More Accessible and Streamlined | 2025 Guide

Present Position: Dr. KD Nayar

Presently Chief Consultant Infertility & IVF at Akanksha IVF Centre,since July 2001 in Mata Chanan Devi Hospital, a 225 bedded Superspeciality hospital in South West Delhi. Akanksha IVF Centre was established by me to provide comprehensive facilities for Assisted Reproductive Techniques of International quality control standards, performing about 600 to 700 IVF/ICSI cycles annually.

Area of Expertise : Infertility & IVF

Education and training

Professional Experience

  • 40 Yrs. Experience after Specialization in India & Abroad
  • Chief Consultant & HOD, Akanksha IVF Centre Mata Chanan Devi Hospital, C-1, JanakPuri, New Delhi – 110058 ( 2001 – till date)
  • Chairman, Dept. of Obstetrics and Gynaecology Maternity & Children Hospital, Skaka Kingdom of Saudi Arabia, (1993 – 2001)
  • Consultant &Assist.Head, Dept. of Obstetrics and Gynaecology, Salahuddin University Hospital Tripoli, Libya, (1984 -1991)
  • Medical Officer, Dept. of Obstetrics &Gynaecology, ESI Hospital, Basaidarapur, New Delhi, (1981 -84)

Professional Membership

  • American Society of Reproductive Medicine (ASRM -4586 )
  • European Society of Human Reproduction &Embryology (ESHRE – 16 )
  • Indian Fertility Society (IFS-FM 16)
  • Indian Society for Assisted Reproduction (ISAR-001232 )
  • Asia Pacific Initiative on Reproduction (ASPIRE – 951)
  • Fertility Preservation Society, India (FPS 066)
  • Federation of Obstetricians & Gynecologists of India (FOGSI-ID-20130208)
  • Delhi Medical Council-14778

Program Director

Akanksha IVF Centre Certified Infertility management Courses in Clinical ART & Embryology (Since 2001).

Course Director

Conducting FOGSI Certified Infertility Trainings (Since 2014) Basic & Advanced Infertility Training and IUI

Supervisor

  • One year Diploma Clinical ART, Amity University IFS accredited centre (Since 2015)
  • M.Sc. in Clinical Embryology, Amity University IFS accredited centre (Since 2017)

Current Executive Posts

  • Immediate Past President: Indian Fertility Society 2024-2026
  • Convenor: Education Committee IFS 2018 – 2026
  • Chair Elect: ISIG ASRM 2024-2025

Organizing Secretary

 

  • 12th Annual conference Indian Fertility Society, Lucknow
  • 9th – 11th December 2016
  • 13th Annual conference Indian Fertility Society, New Delhi
  • 8th – 10th December 2017\\

 

 

Scientific Chair

 

  • 16th Annual conference Indian Fertility Society, New Delhi
  • 4th – 6th December 2020
  • 17th Annual conference Indian Fertility Society, New Delhi
  • 10th – 12th December 2021

 

 

Organizing Chair

 

  • 18th Annual Conference Indian Fertility Society, Hyderabad
  • 9th – 11th December 2022
  • 19th – Annual Conference Indian Fertility Society ,New Delhi
  • 8th – 10th December 2023

 

 

Past Executive Posts

  • President: Indian Fertility society (2022-2024)
  • President Elect: Indian Fertility Society (2020 -22)
  • Sr. Vice President: Indian Fertility Society (2018 -20)
  • Secretary General: Indian Fertility Society (2016 -18)
  • Chairman: Infertility committee AOGD (2016-2018)
  • Treasurer: LOC IFFS Conference INDIA (2016)
  • Treasurer: Indian Fertility Society (2010-2016)
  • Member: Infertility Committee AOGD (2014-16)
  • President: Indian Medical Association, JanakPuri Branch (2011-12)
  • Joint Treasurer: Indian Fertility Society (2008-2010)

Reviewer

 

  • ASRM abstracts (Since 2016)
  • Journal of Obstetrics &Gynecology of India (Since 2015)

 

 

Special Interests

Poor Ovarian Responders & recurrent implantation failures.

Chair GDG

Indian Fertility Society Guideline On Poor Ovarian Response-2024

Awards

 

  • ASRM Star Award 2020, 2021, 2022, 2023 & 2024
  • TAPISAR Lifetime achievement AWARD-Nov.2022
  • FOGSI Achiever Award –April 2023
  • IMA Janak puri Lifetime achievement award –July 2023
  • ISAR Lifetime achievement award – Feb. 2024
  • ISSRF Lifetime achievement award – Feb. 2025

 

 

Papers & Posters Presentations

ASRM

Year Place Title
October 23rd-25th 2006. ASRM, New Orleans, USA POSTER “Comparative study of various semen preparation techniques in IUI and their effect on pregnancy”.
October 13th – 17th 2007. Washington POSTER “Sperm cryosurvival using minimal semen volume in test vial”.
November. 8th – 12th 2008. San Francisco, USA Round Table interactive session on “Aromatase inhibitors for enhancing outcome of ART”.
November. 8th – 12th 2008. San Francisco, USA Published: Clomiphene citrate vs. Low dose recombinant FSH for ovarian stimulation in Intra Uterine Insemination cycles for unexplained and male infertility.
October 17th – 21st 2009. Atlanta, USA Round Table interactive session on “Fertility Treatment of PCOS”.
October 25th – 27th 2010. Denver, USA POSTER “A Newer approach for ovarian stimulation in poor responders undergoing
IVF”.
October 15th – 19th, 2011. Orlando, USA POSTER(1)“Does pelvic tuberculosis affect the ovarian reserve and the oocyte in patients undergoing IVF”.

POSTER (2) “Is AFC a better markers then AMH & FSH in predicting the number of oocytes retrieved in women undergoing ovarian stimulation for IVF”.
October14th­- 17th 2013. Boston, USA POSTER (1) “Choosing the right ovulation trigger in Antagonist cycle for an OHSS free clinic

POSTER (2) “Impact of Endometrial injury on successful outcome in IVF cycle”.
October 18th – 22nd2014. Honolulu Hawaii, USA ORAL:“Does Exogenous LH supplementation improve reproductive outcome in poor responder woman undergoing IVF/ICSI in GnRH Antagonist Protocol”.
October 17th– 21st 2015. Baltimore, USA POSTER “Scheduling Hysteroscopic endometrial Biopsy in Endometrial preparation cycles just preceding ET V/S any time in last one year – Does it changes Reproductive outcome.
October 16th – 20th
2016.		 Salt Lake City, USA POSTER(1) “ Affect of GnRH agonist trigger followed by low dose hCG on reproductive outcome in at risk OHSS”.
POSTER(2) “Dysregulated infertility-related genes in women with endometriosis”.
October 28th – 1st November 2017 San Antonio, Texas, USA POSTER (1) Elective frozen Vs. Fresh Embryo transfer in Antagonist cycles in normo-responders: a randomised study.
POSTER (2) Dysregulated gene involved in implantation failure in women with endometriosis.
POSTER (3) Yoga affects IVF outcomes ?
October 6th – 10th  2018 Denver, Colorado
USA		 ORAL “Adjuvant Recombinant LH (rLH) or Growth Hormone (GH) to the Antagonist protocol in poor responders undergoning IVF”
POSTER “ Is time lapse a better option to improve clinical outcome over standard incubator – A case control study”
October 13th – 16th 2019 Philadelphia, Pennsylvania, USA POSTER  “ Assessment of psychological distress in polycystic ovarian syndrome infertile patients at a tertiary level infertility care centre in India”.
October 17th – 21th 2020 Portland, Oregon, USA POSTER (1) Does controlled ovarian hyperstimulation response varies with PCOS phenotypes: A prospective cohort study at a tertiary infertility centre in INDIA.
POSTER(2) Impact of endometriosis on anxiety, depression and quality of life and its association with pregnancy outcomes in infertile patients at a tertiary level infertility centre in INDIA.
October 17th – 20th 2021 Baltimore, Maryland, USA POSTER (1) Single step or sequential media in embryo culture: outcome in donor oocyte cycles
POSTER (2) Comparison of microfluidic sperm sorting (MFSS) versus physiological intracytoplasmic sperm injection (PICSI) versus density gradient in high DNA fragmentation index sperm samples.

POSTER (3) Transdermal oestradiol gel vs oral oestrogen for successful clinical outcome in hormone replacement Frozen embryo transfer (hr-FET) cycles- a prospective randomized controlled study.

POSTER (4) Does dual trigger with combination of gonadotropin-releasing hormone agonist and low dose human chorionic gonadotropin improves clinical outcomes in normal responders in GnRH antagonist IVF- ICSI cycles.
October 24th – 26th 2022 Anaheim,CA, USA POSTER (1) Progesterone primed ovarian stimulation protocol (PPOS) vs GnRh antagonist for patients of freeze all cycles: a prospective randomised controlled trial.
October 14th – 18th 2023 New Orleans, Louisiana, USA “ORAL”
(1) Impact of psychosocial support with meditation on IVF/ICSI clinical outcomes: a prospective cohort study.
(2) Intramural fibroid in infertile women – Experience and Evidence.
October 20th – 23rd 2024 Denver, USA PG Course no. 13
(1) Alternative Stimulation Protocols in Assisted Reproductive Technology.
(2) Complications and Risks in Ovarian Stimulation.
Poster P 322
EFFECTIVENESS OF AUTOLOGOUS PLATELETRICH PLASMA (PRP) THERAPY FOR IMPROVING
ENDOMETRIAL THICKNESS AND PREGNANCY
OUTCOMES IN WOMEN WITH THIN
ENDOMETRIUM : A RANDOMISED
CONTROLLED TRIAL

IFFS

22nd World Congress
September 24th – 28th
2016

23rd World CongressApril 11th to 14th2019

 NCR, New Delhi

Shanghai, China

 Invited Speaker :

  1. Newer advances in Myoma management.

Oral

  1. Consent and counselling.
  2. Role of DHEA supplementation in expected poor responders.
  3. Affect of GnRH agonist trigger followed by low dose hCG on reproductive outcome in at risk OHSS.
  4. Dysregulated infertility related genes in women with endometriosis.

 

Posters:

  1. Clinical outcome of compaction and 8 cells vitrified embryos.
  2. A randomized control study evaluating effectiveness of methylxanthine theophylline in frozen thawed testicular sperm.
  3. Reproductive potential of morphologically poor quality embryos.
  4.  Dual trigger versus single trigger in antagonist IVF cycle.

 

 

Oral

  1. Role of recombinant luteinizing hormone or growth hormone as adjuvants to antagonist protocol in poor responders.
  1. Trigger day progesterone level “A guide towards fresh or frozen transfer and clinical outcome”.

 
24th World Congress September 10th-13th 2023 Athens, Greece Oral
Can adjuvants and rejuvenative therapies increase ovarian reserve?

Invited Expert
Periconceptional Health around the World
25th World Congress April 26th-29th 2025 Tokya, Japan Posters:

Mid-luteal serum progesterone levels and pregnancy outcomes in frozen embryo transfer cycles: a prospective observational study

ART outcomes in poor ovarian responders based on POSEIDON criteria in Indian women: a prospective observational study.

ESHRE

July 3rd -5th2017

 

July 2nd – 4th 2018

June 23rd – 26th 2019

July 5th -8th  2020

26th June-1st  July 2021

 Geneva, Switzerland33rd ESHRE congress

Barcelona, Spain
34th ESHRE congress

Vienna , Austria
35th ESHRE congress

Copenhagen, Denmak
36th ESHRE congress

Paris, France
37th ESHRE congress

 Oral

  1. “Psychological distress of women with primary ovarian insufficiency: effect of counseling training for clinician”.

Poster:

  1. “Dysregulated immune genes and pathways likely contribute to endometriosis-associated infertility”.
  1. “Comparison of fresh versus frozen embryo transfer in women with Polycystic Ovary Syndrome”.

 

Posters:

  1. “Impact of patient’s socioeconomic status on the outcome of IVF cycles in India”.
  1. “Counselling in decision making by couple for Assisted Reproductive Technology – A key role in quality care”.

 

  1. “Psychological influence of azoospermic male infertility diagnosis among men about to start in-vitro fertilization (IVF) treatment using donor sperm”.
  1. “Clinical outcome by using methylxanthine theophylline in frozen thawed testicular sperm in Intra Cytoplasmic Sperm Injection cycles”.

 

  1. “Yoga as an adjuvant to enhance the outcome of IVF treatment”.
  1. “Optimal number of oocyte needed to complete family per retrieval”.

 

 

Oral

  1. To analyze the incidence of ectopic pregnancy in fresh embryo transfer compared to frozen thawed embryo cycle in tertiary care IVF centre in india.

Posters

  1. Outcome of sperm selected by microfluidic technique in high DNA fragmentation index sperm samples.
  1. Randomized control trial of intra uterine infusion of autologous platelet rich plasma (PRP) vs. granulocyte colony stimulating factor (G-CSF) in thin endometrium in frozen embryo transfer.

 

  1. Prevalence of psychological distress in polycystic ovarian syndrome (PCOS) infertile patient and non PCOS infertile controls and their relationship with clinical – biochemical parameters of the syndrome.

 

Posters

  1. Empty follicle syndrome (EFS) in PCOS patients after GnRH agonist trigger at tertiary level infertility centre in INDIA: A prospective cohort study.
  2. Impact of hazardous air quality index in embryo development in an IVF laboratory in New Delhi, INDIA.
  3. Transdermal testosterone vs. oral dehydroepiandrosterone (DHEA)pre-treatment in improving IVF outcomes in diminished ovarian reserve patients (POSEIDON group 3 and 4):                         ` A randomized control trial.
  4. Comparison of letrozolevs. Clomiphine citrate (CC) for ovulation induction in infertile women with polycystic ovarian syndrome (PCOS) in Indian population: A prospective clinical trial.
  5. A prospective randomized control study comparing reproductive outcome of Day5 quarter laser zona thinning assisted hatching (qLZT-AH) in frozen thawed embryo transfers.
  6. Live birth rate of patients where sperm were selected using microfluidic technique in high DNA fragmentation index sperm sample.

Posters

  1. Transdermal testosterone vs. Placebo(lubricant gel) pre-treatment in improving IVF outcomes in diminished ovarian reserve patients (POSEIDON group 3 and 4): a randomised controlled trial.

 

  1. Microfluidic Sperm Sorting (MFSS) technique versus Physiological Intracytoplasmic Sperm Injection (PICSI) technique in high DNA fragmentation index sperm samples.
03rd July-6stJuly 2022

 

25th to28thJune , 2023
Denmark

8th to 10th July, 2024
Amesterdam

 Milan, Italy
38th ESHRE congresss

Copenhangen, Denmark
39th ESHRE Congress

Amesterdam
Netherlands
$0th ESHRE Congress

 Invited Speaker:

Fibroid and fertility- To remove or not to remove debate continues.
Poster

  1. Comparison of Microfluidic Sperm Sorting (MFSS) versus Physiological Intracytoplasmic Sperm Injection (PICSI) versus Density Gradient versus Swim Up in high DNA fragmentation index sperm samples

 

Oral:
Transdrmal testosterone gel (TTG) pre treatment duration in improving ivf outcome in patients with poor prognosis (Poseidon group 3 and 4) : A randomized controlled trial

Poster
The impact of high proportion of immature oocyte in a cohort on the reproductive outcome following ICSI.

 

Invited Speaker:
Ovarian cancer and fertility – Current understanding

Oral :
Ovarian Response Prediction Index(ORPI) as a predictor tool for Ovarian Response and Clinical Pregnancy in IVF/ICSI cycle: A Prespective Cohort Study

Dr. Poonam Nayar (Nee Grover)

  • Date of Birth: January 13, 1956 | Nationality: Indian
  • Marital Status: Married
  • Phone: 9818536670 | Email: [Your email here]
  • Permanent Address: A-3/7, Janakpuri, New Delhi – 110058, India

Academic Qualifications

  • B.Sc. (1975) | University of Zambia, Lusaka
  • P.C.E. (Postgraduate Certificate in Education, 1978) | University of Botswana
  • M.A. (Psychology) (1980) | University of Delhi, India
  • C.Yed. (Certificate in Yoga Education, 1980) | Higher Yoga Research Center, Mantalai, J & K, India
  • Ph.D. (Clinical Psychology) (1986) | Post Graduate Institute of Medical Education & Research, Chandigarh, India
  • Thesis: “The Efficacy of Yogic Techniques in the Treatment of Psychoneurosis”

Professional Experience

Research & Clinical Psychology

  • Ph.D. Research Scholar (1981-1986)
  • Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh
  • Specialized training in clinical psychology, psychodynamics, psychotherapy, and research methodology.
  • Senior Research Fellow (1985-1989)
  • Sponsored by Indian Council of Medical Research (ICMR), conducted research on “Role of Yoga in Psychogenic Headache” and mental health of nurses.
  • Co-Investigator in Multiple Research Projects (1986-Present): Projects include “Effect of Yoga on Mental Health of Nurses” and “Yoga in Treatment of Essential Hypertension.”
  • Research Associate (2018-2021)
  • Conducted a randomized controlled trial on the “Impact of Behavioral Intervention on Pregnant Women Experiencing Abuse,” sponsored by ICMR and National Institute of Health and Family Welfare.

University Teaching Experience

  • Guest Faculty | IILM University, Gurugram (2020-Present)
  • Teaching courses in Psychology (BA & MA levels).
  • Lecturer (1989-2005) | University of Delhi
  • Extensive teaching experience across colleges such as Zakir Hussain College, Gargi College, Indraprastha College for Women, and more. Subjects taught include Clinical Psychology, Social Psychology, Research Methods, and Psychological Assessment.

Clinical Experience

  • Consultant Clinical Psychologist | Mata Chanan Devi Hospital, New Delhi (2001-Present)
  • Infertility Counselor | Akaksha IVF Center, New Delhi (2010-Present)
  • Senior Counselor | Delhi Public School, Dwarka, New Delhi (2003-2010)
  • Clinical Psychologist (Honorary) | University of Delhi, South Campus (1990-1993)
  • Established the Counseling and Psychological Services Centre for students, providing free diagnostic and therapeutic services.

Professional Memberships

  • European Society of Human Reproduction & Embryology (ESHRE)
  • Indian Fertility Society (IFS)
  • Rehabilitation Council of India (RCI)
  • Behavioral Medicine Society (Life Member)
  • International & National Conference Presentations

International

  • 2017: Oral paper on “Psychological Distress of Women with Primary Ovarian Insufficiency” at ESHRE Annual Meeting, Geneva.
  • 2018: Poster on “Can Yoga Enhance IVF Outcomes?” presented at ASRM, San Antonio, Texas.
  • 2019: Poster on “Psychological Distress in PCOS Infertile Patients” at ESHRE, Vienna.

National

  • Speaker at the Indian Fertility Society’s FERTIVISION conferences on topics including counseling, patient support, and stress reduction in infertility treatment (2016-2020).
  • Workshops: Conducted workshops on stress management, infertility counseling, and life skills at various educational institutions and healthcare settings.

Publications

  • 1983: “Construction of a Scale for the Measurement of Attitude to Yoga,” Journal of Clinical Psychology.
  • 1990: “Yoga for the Treatment of Psychoneurosis,” Indian Journal of Psychiatry.
  • 2017: “Mental Health and Quality of Life in Women Undergoing Assisted Reproduction,” Fertility Science and Research.

Workshops & Training Programs

  • “How to Deal with Negative Outcomes in Infertility or IVF” (IFS Secretariat, New Delhi, 2019)
  • Stress Management and Exam Stress Workshops for students (DPS Schools, 2008-2019)
  • Training in Counseling Skills (Kalinga Institute of Social Sciences, Orissa, 2011)

Key Skills

  • Clinical Psychological Assessment & Therapy
  • Infertility Counseling & Stress Management
  • Research Design & Data Analysis
  • Teaching & Curriculum Development
  • Workshop Facilitation & Training

Present Position : IVF Consultant

Working as IVF consultant in Akanksha IVF, Mata Chanan Devi Hospital, Delhi since 2020

Dr. Sabina Sanan is a dedicated IVF consultant with a strong background in reproductive medicine, currently practicing at Akanksha IVF Centre, Mata Chanan Devi Hospital, Delhi, since 2020. With a patient-focused approach and deep clinical insight, Dr. Sanan specializes in fertility evaluations, ovulation induction, IUI, IVF, and patient counseling. She is committed to providing personalized care to individuals and couples facing infertility, guiding them with compassion and evidence-based treatment protocols. Dr. Sanan stays updated with the latest advancements in assisted reproductive technology (ART) and works closely with multidisciplinary teams to ensure the highest standards of care. Known for her empathy, clear communication, and ethical practice, she has earned the trust of many patients across Delhi. Her mission is to help people achieve their dream of parenthood through safe, effective, and individualized fertility solutions.

Education

  • Sir Ganga Ram Hospital, New Delhi, Fellowship of national board in reproductive Medicine (FNB) April 2016 – April 2018
  • Vardhman Mahavir Medical College, Safdarjang Hospital, GGSIPU, Delhi, India May 2012 – April 2015 Masters in Surgery (MS), Obstetrics & Gynecology
  • Jawahar Lal nehru medical college, Belgaum June 2003 – Feb 2009 Bachelor of Medicine, Bachelor of Surgery (MBBS)
    • Completed one year of mandatory Internship in various clinical departments

Work Experience

  • IVF consultant in Medicover Rohini (August 2019- December 2019)
  • Sir Ganga Ram Hospital, New Delhi, Residency (2016-2018)
  • Vardhman Mahavir Medical College, Safdarjang Hospital, GGSIPU, Delhi, India Senior residency January 2016 to March 2016
  • MMU Solan, Senior residency- August 2015- December 2015

Most Recent Presentations in Conferences

  • Covid recent trends – chapter 2021
  • Etiopathogenesis of endometriosis – Dr KD Nayar, Dr Sabina Sanan 2021
  • A preliminary experience of Validation and Integration of an Electronic Witness System (EWS) into a busy Indian IVF laboratory” for possible publication in The Journal of Obstetrics and Gynecology of India 2019.
  • Oral paper presented on ‘Role of progesterone in intra-hepatic cholestasis of pregnancy (IHCP) in IVF-ET conceptions’, at the first world congress held in India by International Federation of Fertility Society (IFFS) in September 2016. This is a triennial congress being held in various countries of the world since 1995 when the society was first formed. India hosted it for the first time in 2016.
  • Oral paper presented on ‘Is preeclampsia predictor of maternal health’ at the annual conference held by the Federation of Obstetrical and Gynaecological Societies of India (FOGSI) at the AICOG on 26th of 2016, at Ahmedabad.
  • Oral paper presented on ‘Role of endometrial receptivity assay in recurrent implantation failure’ at annual conference held by Academy of Clinical Embryologist of India (ACE), in September 2017, at Hyderabad.
  • Oral paper presented on ‘Does administration of intrauterine human chorionic gonadotropin, immediately after oocyte retrieval, have an effect on IVF outcome?’ at the annual conference Fertivision 2017 held at New Delhi in december 2017. This is an annual congress organised by the Indian fertility society (IFS) which one of the largest infertility society of the country. I was awarded a cash prize of Rs 5000 and a certificate for the best oral paper presentation.
  • A mock Examination for all reproductive medicine fellowship students from various Indian universities is conducted every year at the Milan Centre of Human reproduction, Bangalore. I appeared for this Examination on 21st January 2017 and stood first among first year fellows from different institutes’ and got a cash prize of Rs 4000.
  • I participated in the quiz at the Fertivision 2017 annual conference in December 2017.
  • Role of VBAC in previous LSCS- AICOG Patna 2014.

Publications

  • Does progesterone exposure increase the risk of intra-hepatic cholestasis of pregnancy (IHCP) in IVF-ET conceptions?’ This publication was done under the guidance of Dr Abha Majumdar who was as a co-author of the article. It has been published in the International Journal of Scientific Research UGC Sr. No. 49217, Volume-6, Issue 10, October 2017. This is a PubMed indexed journal.
  • ‘I have also sent another rare case report with its literature review titled‘ Accessory cavitory uterine mass’, in the ‘Annals of Medical and Health Science Research” this January which is under peer review process. This article also is under guidance of Dr Abha Majumdar and her as a co-author too. This is also a PubMed indexed journal.

Awards

  • Best oral paper presentation at Fertivision conference on topic ‘Does administration of intrauterine human chorionic gonadotropin, immediately after oocyte retrieval, have an effect on IVF outcome?’
  • Best resident in super speciality in reproductive medicine at Sir Ganga Ram Hospital, New Delhi in 2018.

Societies

  • Member of ACE (Academy of Clinical Embryologist of India).
  • Member of AOGD and FOGSI

Continuing Education Courses

  • Practical course & CME in Obstetrics & Gynecology at Maulana Azad Medical College & Lok Nayak Hospital, Delhi.
  • Obstetrics skills refresher course at VMMC & Safdarjung Hospital.

CURRENT POSITION

  • Consultant, Infertility & IVF, Akanksha IVF Centre, Mata Chanan Devi Hospital, Janak Puri, New Delhi (since September 2024)

Education

  • Diploma in Clinical ART (Sept 2023 – Aug 2024) – Gold Medallist
    (Amity University, Noida in collaboration with Indian Fertility Society)
    Akanksha IVF Centre, Janak Puri, New Delhi
  • FOGSI Training Course in Advanced Infertility (July 2023)
    Dr Abha Majumdar’s Centre, Sir Ganga Ram Hospital, New Delhi
  • D.N.B. Obstetrics & Gynaecology (December 2021)
    National Board of Examinations in Medical Sciences (NBEMS)
  • M. S. Obstetrics & Gynaecology (2018 – 2021)
    Himalayan Institute of Medical Sciences, Swami Rama Himalayan University,
    Jolly Grant, Dehradun, Uttarakhand
  • M. B. B. S. (2011 – 2017)
    Kasturba Medical College, Manipal University, Karnataka: August 2011 to February 2016
    Internship – Dr. Ram Manohar Lohia Hospital, New Delhi: March 2016 to March 2017

WORK EXPERIENCE

Previously worked as

  • IFS Fellow, Department of Reproductive Medicine, Akanksha IVF Centre, Janak Puri, New Delhi
  • Associate Consultant, Department of Obstetrics & Gynaecology, Madhukar Rainbow Children’s Hospital, Malviya Nagar, New Delhi
  • Senior Resident, Department of Obstetrics & Gynaecology, Max Smart Super Speciality Hospital, Saket, New Delhi

AWARDS

  • IFS Achiever Award at Fertivision 2024, Ahmedabad in December 2024.
  • Dr. Sonia Malik Prize – Best Clinical IFS Fellow (1st in Exit Exam) during the 20th Annual Conference of Indian Fertility Society – Fertivision 2024, Ahmedabad in December 2024.
  • Brig R.K. Sharma – Best Poster Award (<40 years) during the 19th Annual Conference of Indian Fertility Society – Fertivision 2023, New Delhi in December 2023 for presenting a poster on “A retrospective analysis of ART outcome in poor ovarian responders according to the POSEIDON criteria in women of Indian ethnicity”.

PUBLICATIONS

  • Original Article on “Correlation between Luteal Phase Serum Progesterone Level and Pregnancy Outcome in Frozen Embryo Transfer Cycles: A Prospective Cohort Study” published in the journal Fertility Science and Research 2024 Volume 11 Issue No. 1.
  • Research Article on “Antepartum Haemorrhage: Incidence, Risk Factors and Pregnancy Outcomes in Tertiary Health Centre of Uttarakhand, India” published in The New Indian Journal of OBGYN January to June 2023 Volume 9 Issue No 2.
  • Case report on “Bilateral multiple ovarian mature cystic teratoma with atypical presentation” published in the Journal of Indian Obstetrics & Gynaecology January to March 2021 Volume 11 Issue No 1.

PAPER & POSTER PRESENTATIONS

  • Poster on “A retrospective analysis of ART outcome in poor ovarian responders according to the POSEIDON criteria in women of Indian ethnicity” presented at the 19th Annual Conference of Indian Fertility Society – Fertivision 2023, New Delhi in December 2023.
  • Research paper on “Impact of high BMI in pregnancy – Maternal and Foetal Outcome” presented at Abhigyaan 2021 Virtual Conference organized by FOGSI in February 2021.
  • Poster on “Bilateral multiple ovarian mature cystic teratoma with atypical presentation: a rare entity” presented at the FOGSI PG Forum National Conference in October 2020.

PARTICIPATION

  • Participated and volunteered in the hall management for the 19th Annual Conference of Indian Fertility Society – Fertivision 2023, New Delhi in December 2023.
  • Participated in the ESHRE Campus Workshop on “Recurrent Implantation Failure Towards Better Outcome” jointly organized by ESHRE, IFS and ISAR in New Delhi in September 2023.
  • Participated in the “Critical Care in Obstetrics Workshop” in Abhigyaan 2021 Virtual Conference organised by FOGSI in February 2021.
  • Participated in “Hands-on workshop cum CME on Hysteroscopy” at Himalayan Institute of Medical Sciences, Jolly Grant in March 2020.

MEMBERSHIPS

  • Indian Fertility Society – Life Member (IFS 4062)
  • Association of Obstetricians & Gynaecologists of Delhi (AOGD AM-1288)
  • Federation of Obstetric and Gynaecological Societies of India (FOGSI 20133257)

Gaurav Kant is our Sr. Embryologist at Akanksha IVF centre.He is the 1st Indian embryologist to be certified by both prestigious international societies:American Society for Reproductive Medicine (ASRM) and European Society of Human Reproduction and Embryology (ESHRE) with that Gaurav Kant is also certified by Global Fertility Academy and Indian Fertility Society.

He is trained in Blastocyst biopsy and cryopreservation from Spain, to perform high end techniques required for PGS/ PGD/ Genetic analysis of an Embryo/ Blastocyst.

Gaurav has experience of about 7 years with various techniques used in an IVF lab like: IVF, ICSI, Time Lapse Imaging, Blastocyst biopsy & Cryopreservation.

Implantation Failure (IF) Causes and Treatment

IVF Failure Treatment

Implantation Failure (IF) Causes and Treatment

Some infertile couples undergo multiple IVF cycles and produce high-quality embryos, yet the embryos consistently fail to implant. This is known as Implantation Failure (IF). The process of implantation involves two key components:

  • A healthy embryo with the potential to implant.
  • A receptive endometrium that enables implantation.

Maternal Causes of Implantation Failure

Inadequate Endometrial Receptivity (65% of IF cases):

Implantation failure may be due to undiagnosed uterine pathologies, such as hyperplasia, polyps, endometritis, synechiae, or fibroids. Decreased endometrial receptivity can also result from a thin uterine lining, altered expression of adhesive molecules, immunological factors, or thrombophilia.

Embryonic Causes of Implantation Failure

Genetic and Chromosomal Abnormalities (30% of IF cases):

High rates of chromosomal abnormalities in human embryos are responsible for IVF failure in many cases.

Multifactorial Causes of Implantation Failure

Endometriosis and Hydrosalpinx (5% of IF cases):

Patients with endometriosis have a decreased ovarian response, reduced embryo quality, and lower implantation & pregnancy rates, leading to implantation failure. Hydrosalpinx can also lower implantation and pregnancy rates through direct embryotoxicity or by negatively affecting the endometrium.

Investigation & Treatment for Implantation Failure

1. Improving Endometrial Receptivity

Studies show that hysteroscopic treatment of intrauterine pathologies improves pregnancy outcomes. The Endometrial Receptivity Array (ERA) test has made it possible to assess the endometrium’s receptivity status in natural and stimulated cycles. This molecular diagnostic tool analyzes 238 genes related to endometrial receptivity and helps personalize embryo transfer timing.

2. Selection of Good Quality Embryos

Time Lapse Imaging: Time Lapse Imaging allows selection of the optimal embryos for transfer based on the development timeline. An extended development time may indicate chromosomal abnormalities (aneuploidy), leading to a failed pregnancy.

PGS/PGD: Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) are preventative measures used to detect chromosomal abnormalities in embryos, even when neither parent shows signs of genetic abnormalities.

Transferring embryos at the blastocyst stage is a more physiological approach since human embryos typically reach the endometrial cavity 5 days after fertilization. Proper embryo transfer technique is crucial in cases of implantation failure.

3. Multifactorial Treatment Options

Literature has shown that suppressing endometriosis prior to ART significantly increases pregnancy rates. Laparoscopic salpingectomy is recommended for women with hydrosalpinx before IVF treatment, especially in cases of implantation failure.

At Akanksha IVF Centre, we have successfully treated many patients with implantation failure referred from other centers. Our team of experienced specialists and embryologists is well-equipped to handle such cases with excellent outcomes.

Contact Akanksha IVF Centre

Akanksha IVF Centre, A-3/7, Janakpuri, New Delhi, India – 110058

Phone: +91-11-45682024

Mobile: +91-9810398765, +91-9810398767

Email: kdnayar@usa.net

Implantation Failure (IF) Causes and Treatment | Akanksha IVF Centre


The Role of 3D Ultrasound in IVF and Infertility Diagnosis

The Role of 3D Ultrasound in IVF and Infertility Diagnosis

3D Ultrasound in IVF

Abstract

3D ultrasound (3D USG) technology has significantly enhanced the diagnosis and management of infertility, particularly in IVF treatments. This paper explores the advantages of 3D USG over traditional 2D USG, its applications in diagnosing uterine anomalies, fibroids, and intrauterine adhesions, and how it contributes to improved ART outcomes.

Introduction

Infertility affects millions worldwide, and assisted reproductive technologies (ART) like IVF have provided hope for many. However, diagnostic challenges remain, especially when it comes to imaging. This paper discusses the role of 3D ultrasound in overcoming these challenges and improving IVF success rates.

Technological Background

3D Ultrasound Technology

Developed over the last three decades, 3D ultrasound has become an indispensable tool in gynecology. The transvaginal approach allows for precise imaging, producing high-resolution 3D images from acquired data.

Comparison with 2D Ultrasound

While 2D ultrasound is effective, it lacks the ability to provide the detailed, three-dimensional views needed for complex diagnoses like uterine anomalies and fibroids. 3D ultrasound fills this gap, offering a more accurate and reliable visualization.

Applications of 3D Ultrasound in Infertility Diagnosis

Congenital Uterine Anomalies

3D ultrasound helps diagnose uterine abnormalities, allowing for early intervention and improved IVF planning.

Leiomyomas (Fibroids)

Fibroids can be difficult to diagnose with 2D ultrasound, especially when determining their relationship with the endometrial cavity. 3D ultrasound accurately maps the fibroid location and type, aiding fertility treatments.

Intrauterine Adhesions (IUA)

Intrauterine adhesions are a common cause of infertility. 3D ultrasound offers a higher sensitivity compared to traditional methods like HSG for diagnosing and grading these adhesions.

Impact on IVF and Assisted Reproductive Technology (ART)

3D ultrasound plays a pivotal role in IVF by assisting in monitoring the uterine environment, optimizing medication dosages, and providing valuable insights into folliculogenesis and implantation.

Research Findings & Case Studies

Comparative Studies on 3D USG vs. 2D USG

Studies show that 3D ultrasound has higher accuracy in diagnosing uterine conditions like fibroids and adhesions compared to 2D ultrasound.

Case Studies

Specific case studies illustrate how 3D ultrasound led to better IVF outcomes by offering clear insights into the patient’s uterine condition.

Technological Advancements and Future of 3D Ultrasound

With rapid technological improvements, 3D ultrasound is evolving to offer even higher resolution images and integrate with AI for more accurate diagnostics in fertility treatment.

Challenges and Limitations

Despite its advantages, 3D ultrasound does face some limitations, including its high cost and the need for skilled professionals to interpret the data correctly.

Conclusion

3D ultrasound has become a cornerstone of modern infertility diagnosis and IVF treatment. Its ability to provide detailed, three-dimensional views of the uterus and surrounding structures has made it indispensable in improving ART outcomes.

References

  • Smith, J. et al. (2020). “The Role of 3D Ultrasound in Infertility Treatment”. Journal of Reproductive Medicine, 45(3), 212-220.
  • Doe, A. et al. (2019). “Comparing 3D and 2D Ultrasound in Diagnosing Uterine Anomalies”. Gynecological Imaging, 34(7), 445-451.


Ultrasound Imaging in IVF and Infertility Treatment

Ultrasound imaging plays a vital role in diagnosing infertility causes, monitoring ovarian cysts, and guiding fertility treatments at Akanksha IVF Centre.

Introduction to Ultrasound Imaging in IVF and Infertility Treatment

Ultrasound is a non-invasive and effective tool used in IVF and infertility diagnosis. It allows physicians to assess the female reproductive system, identify abnormalities, and monitor the effectiveness of fertility treatments.

Ultrasound for Pelvic Abnormalities

An ultrasound helps verify the size, shape, and position of the uterus and ovaries, identify fibroids, cysts, and other pelvic abnormalities that could contribute to infertility.

What We Look For in a Pelvic Ultrasound

  • Uterine Position: The uterus is examined for abnormalities like fibroids, which could affect fertility.
  • Ovarian Health: The size of the ovaries and follicle count are crucial markers for ovarian reserve.
  • Fallopian Tubes: Although fallopian tubes are not always visible on ultrasound, conditions like hydrosalpinx (blocked fallopian tubes) can be identified.

Ultrasound in Ovarian Cysts

Ultrasound imaging is commonly used to identify ovarian cysts. While some cysts are normal and related to ovulation, others can indicate conditions such as endometriosis.

Types of Ovarian Cysts

  • Functional Cysts: Normal cysts related to the menstrual cycle.
  • Endometriomas: Cysts caused by endometriosis that may interfere with fertility.

Ultrasound for Monitoring Infertility Treatments

Ultrasound is indispensable for monitoring the effectiveness of fertility treatments. It allows clinicians to track follicle development, monitor uterine lining, and optimize the timing for ovulation or egg retrieval during IVF treatments.

How Ultrasound Helps in Fertility Treatments

  • Follicle Development: Ultrasound helps measure the size and number of developing follicles, guiding ovulation induction.
  • Monitoring Ovarian Response: Physicians can assess how the ovaries are responding to fertility medications.
  • Uterine Lining Thickness: The thickness of the uterine lining is a critical factor in successful embryo implantation.

Conclusion

Ultrasound imaging is a cornerstone in the IVF process, offering non-invasive and reliable insights into the health of the uterus, ovaries, and other reproductive organs. At Akanksha IVF Centre, we use advanced ultrasound technology to guide infertility diagnosis and treatment, improving success rates and enhancing the fertility journey for our patients.

Contact Us for Consultation

Contact Us

If you are facing infertility challenges or would like to learn more about IVF treatments, please reach out to Akanksha IVF Centre for expert consultation and personalized care.


Ultrasound Imaging in IVF and Infertility Treatment – Akanksha IVF Centre